You are here: Industry Insights > Epilepsy

News List

NeuroPace closes $74 million equity funding to accelerate Epilepsy treatment biospectrumasia
October 26, 2017
NeuroPace developed the world’s first and only closed-loop brain-responsive neurostimulation system shown to significantly reduce seizure frequency
Eisai introduces first-in-Class Epilepsy Treatment Fycompa (Perampanel) in India biospectrumasia
August 23, 2017
Epilepsy is a condition that affects the brain and causes repeated seizures. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.
Latency of seizures determined by diet europeanpharmaceuticalreview
August 21, 2017
Researchers have connected docosahexaenoic (DHA) synthesis to oestrogen production and consequentially brain health…
Noted experts critically evaluate benefits of medical marijuana for treatment of epilepsy worldpharmanews
May 27, 2017
Although cannabis had been used for many centuries for treatment of seizure disorders, medical use became prohibited in the 20th century.
Cannabidiol reduces seizures by half in severe epilepsy, study suggestsCannabidiol reduces seizures www.pharmafile
April 20, 2017
A new large-scale study from the American Academy of Neurology has suggested that cannabidiol, a molecule derived...
Epilepsy: Another Potential Zika Threat to Babies drugs.com
April 18, 2017
Beyond its known links to birth defects and other problems, the Zika virus may also trigger cases of epilepsy in infants, warn experts from the U.S. Centers for Disease Control and Prevention.
Orphan status for GW’s rare epilepsy drug pharmatimes
March 31, 2017
London, UK-based GW Pharmaceuticals’ cannabinoid Epidiolex has been awarded Orphan status by European regulators as a treatment for Lennox-Gastaut Syndrome (LGS), a rare and severe form of childhood-onset epilepsy.
Bial and Eisai receive positive opinion for Zebinix to treat focal onset epilepsy pharmaceutical-technology
March 30, 2017
Bial and Eisai have announced the receipt of a positive opinion for Zebinix (eslicarbazepine acetate) from the European Medicine Agency's Committee for Medicinal Products for Human ...
Swansea University scientists participate in study into genetics of common epilepsy pharmaceutical-technology
March 15, 2017
Academics from Swansea University have participated in a study designed to assess the contribution of genome-wide, ultra-rare genetic variation in common epilepsy.

Previous page 1 2 3 4 5 6 Next page